Loading the company…
Loading the company…
Families: Aneurysm & intracranial embolization, Thrombectomy, IVC filters & venous stents, Tumor & fibroid embolization.
All companies · Product and company coverage
In the last ten years FDA made 8 decisions for Balt (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2025 (3). The latest was on 2026-01-27.
| Family | Decisions on record |
|---|---|
| Aneurysm & intracranial embolization | 5 |
| Thrombectomy, IVC filters & venous stents | 2 |
| Tumor & fibroid embolization | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-01-27 | 510(k) | K254221 | Optima Coil System (OptiOne Coil System) |
| 2025-09-26 | 510(k) | K252700 | Optima Coil System (Optima Packing Coil System) |
| 2025-06-03 | 510(k) | K243948 | Raptor Aspiration Catheter; Balt Aspiration Tubing Set |
| 2025-05-30 | 510(k) | K251383 | Prestige Coil System (Prestige Packing Line Extension) |
| 2024-09-27 | 510(k) |
In 2025, Balt reported engagement with 664 surgeons and other clinicians in the states MedaRep covers, worth $316K in consulting, speaking, meals and travel for its device products, the most in Texas ($50K to 88). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Texas ($50K, 88 engaged), Florida ($32K, 40 engaged), California ($30K, 120 engaged), Tennessee ($20K, 11 engaged), Illinois ($18K, 29 engaged).
| K242582 |
| Optima Coil System (OptiBlock Line Extension) |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Balt.